Medpace Holdings, Inc.·4

Apr 2, 4:42 PM ET

Kraft Robert O. 4

Research Summary

AI-generated summary

Updated

Medpace (MEDP) Director Robert Kraft Converts 33 RSUs

What Happened

  • Robert O. Kraft, a director of Medpace Holdings, had 33 restricted stock units (RSUs) convert into 33 shares on March 31, 2026 (reported on Form 4 filed April 2, 2026). The filing shows 33 shares were acquired by conversion (derivative exercise/conversion) and 33 shares were disposed of at $0.00, indicating the shares were surrendered to satisfy tax withholding rather than sold on the open market. No cash proceeds are reported.

Key Details

  • Transaction date: 2026-03-31; Form 4 filed: 2026-04-02 (timely filing).
  • Converted/vested: 33 RSUs → 33 shares (acquired via derivative conversion, code M).
  • Disposed: 33 shares at $0.00 (likely tax withholding; disposition code indicates surrender, not a market sale).
  • Footnotes: F1 — each RSU = right to one share; F2 — these RSUs were part of a 130-RSU grant on Nov 28, 2025 vesting in four ~equal installments (Mar 31, Jun 30, Sep 30, Dec 31, 2026), so ~33 shares vested this installment.
  • Shares owned after the transaction are not specified in the provided filing excerpt.

Context

  • This was a routine RSU vesting and tax-withholding event, not an open-market purchase or sale that signals a change in investment stance. The $0.00 disposal indicates shares were withheld/surrendered for taxes rather than sold for cash.